These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2139523

  • 1. Sequential alternate administration of tamoxifen and medroxyprogesterone acetate in advanced breast cancer: clinical-biological randomized study.
    De Lena M, Tommasi S, Schittulli F, Lorusso V, Paradiso A.
    Tumori; 1990 Apr 30; 76(2):190-5. PubMed ID: 2139523
    [Abstract] [Full Text] [Related]

  • 2. Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancer.
    Gundersen S, Kvinnsland S, Lundgren S, Klepp O, Lund E, Børmer O, Høst H.
    Breast Cancer Res Treat; 1990 Nov 30; 17(1):45-50. PubMed ID: 2151369
    [Abstract] [Full Text] [Related]

  • 3. Alternating sequential endocrine therapy: tamoxifen and medroxyprogesterone acetate versus tamoxifen in postmenopausal advanced breast cancer patients.
    Beltrán M, Alonso MC, Ojeda MB, Izquierdo A, Ferrer J, Picó C, Anglada L, Catalán G, Batiste-Alentorn E, Tusquets I.
    Ann Oncol; 1991 Jul 30; 2(7):495-9. PubMed ID: 1832944
    [Abstract] [Full Text] [Related]

  • 4. Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer.
    Noguchi S, Yamamoto H, Inaji H, Imaoka S, Koyama H.
    Jpn J Cancer Res; 1989 Mar 30; 80(3):244-8. PubMed ID: 2524460
    [Abstract] [Full Text] [Related]

  • 5. Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group.
    Byrne MJ, Gebski V, Forbes J, Tattersall MH, Simes RJ, Coates AS, Dewar J, Lunn M, Flower C, Gill PG, Stewart J.
    J Clin Oncol; 1997 Sep 30; 15(9):3141-8. PubMed ID: 9294477
    [Abstract] [Full Text] [Related]

  • 6. Oral high-dose medroxyprogesterone acetate versus tamoxifen. A randomized crossover trial in postmenopausal patients with advanced breast cancer.
    van Veelen H, Willemse PH, Tjabbes T, Schweitzer MJ, Sleijfer DT.
    Cancer; 1986 Jul 01; 58(1):7-13. PubMed ID: 2939943
    [Abstract] [Full Text] [Related]

  • 7. [Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer].
    Noguchi S, Yamamoto H, Inaii H, Koyama H.
    Gan To Kagaku Ryoho; 1989 Nov 01; 16(11):3555-8. PubMed ID: 2530936
    [Abstract] [Full Text] [Related]

  • 8. Modalities and results of a combined anti-estrogenic therapy by means of tamoxifen and medroxyprogesterone in gynecologic cancerology.
    Bonte J, Janssens JP, Ide P.
    Eur J Gynaecol Oncol; 1986 Nov 01; 7(1):45-50. PubMed ID: 2938955
    [Abstract] [Full Text] [Related]

  • 9. [Hormonotherapy of metastatic breast cancer with tamoxifen and medroxyprogesterone acetate. Randomized trial comparing alternating sequences with successive applications].
    Mauriac L, Durand M, Bonichon F, Chauvergne J.
    Bull Cancer; 1986 Nov 01; 73(2):148-54. PubMed ID: 2942203
    [Abstract] [Full Text] [Related]

  • 10. Cyclic and sequential therapy with tamoxifen and medroxyprogesterone acetate in metastatic breast cancer.
    Nemoto T, Patel JK, Rosner D, Dao TL, Halvorson H.
    J Surg Oncol; 1989 Aug 01; 41(4):226-9. PubMed ID: 2526907
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic effect of tamoxifen alone versus tamoxifen in combination wtih gestagen and oestrogen in advanced breast cancer.
    Mouridsen HT, Palshof T, Rose C.
    Recent Results Cancer Res; 1980 Aug 01; 71():169-77. PubMed ID: 6988913
    [Abstract] [Full Text] [Related]

  • 12. [Effectiveness of combination hormonal therapies in advanced or recurrent breast cancer--a randomized trial of tamoxifen (TAM), medroxyprogesterone acetate (MPA), their simultaneous combination, and an alternating sequential combination of TAM plus MPA].
    Sonoo H, Senoo T, Nishiki M, Morimoto T, Takashima S.
    Gan To Kagaku Ryoho; 1996 Mar 01; 23(4):447-54. PubMed ID: 8678496
    [Abstract] [Full Text] [Related]

  • 13. Clinical trial of combined hormone therapy (MAP + TAM) for metastatic breast cancer.
    Pannuti F, Martoni A, Piana E, Tomasi L, Grieco A, Farris A, Saccani F, Baroni M.
    Chemioterapia; 1984 Aug 01; 3(4):211-5. PubMed ID: 6241846
    [Abstract] [Full Text] [Related]

  • 14. [Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].
    Giralt E, Jouve M, Palangie T, Bretaudeau B, Asselain B, Magdelenat H, Merle S, Zajdela A, Pouillart P.
    Bull Cancer; 1984 Aug 01; 71(1):22-9. PubMed ID: 6324934
    [Abstract] [Full Text] [Related]

  • 15. Sequential combination of tamoxifen and high dose medroxyprogesterone acetate: therapeutic and endocrine effects in postmenopausal advanced breast cancer patients.
    Gasparini G, Canobbio L, Galligioni E, Fassio T, Brema F, Crivellari D, Villalta D, Di Fronzo G, Talamini R, Monfardini S.
    Eur J Cancer Clin Oncol; 1987 Oct 01; 23(10):1451-9. PubMed ID: 2960532
    [Abstract] [Full Text] [Related]

  • 16. [A comparative study with 5'-DFUR alone or in combination with tamoxifen (TAM) or medroxyprogesterone acetate (MPA) for advanced or recurrent breast cancer].
    Takatsuka Y, Yayoi E, Miyauchi K, Aikawa T, Maeura Y, Hirai T, Kotsuma Y.
    Gan To Kagaku Ryoho; 1992 May 01; 19(5):631-6. PubMed ID: 1533755
    [Abstract] [Full Text] [Related]

  • 17. Medroxyprogesterone acetate (MAP) and tamoxifen (TMX) plasma levels after simultaneous treatment with 'low' TMX and 'high' MAP doses.
    Camaggi CM, Strocchi E, Canova N, Costanti B, Pannuti F.
    Cancer Chemother Pharmacol; 1985 May 01; 14(3):229-31. PubMed ID: 3158448
    [Abstract] [Full Text] [Related]

  • 18. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method].
    Kurebayashi J, Horiuchi R, Nakamura T, Iino Y, Ishida T, Takigawa H, Izuo M.
    Nihon Naibunpi Gakkai Zasshi; 1987 Nov 20; 63(11):1351-63. PubMed ID: 2965035
    [Abstract] [Full Text] [Related]

  • 19. Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.
    Fisher B, Redmond C, Legault-Poisson S, Dimitrov NV, Brown AM, Wickerham DL, Wolmark N, Margolese RG, Bowman D, Glass AG.
    J Clin Oncol; 1990 Jun 20; 8(6):1005-18. PubMed ID: 2189950
    [Abstract] [Full Text] [Related]

  • 20. Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12-dimethylbenz[a-anthracene-induced rat mammary tumors in relation to hormone receptors.
    Tominaga T, Yoshida Y, Kitamura M, Kosaki G.
    Jpn J Cancer Res; 1985 Nov 20; 76(11):1120-5. PubMed ID: 2935517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.